Valsartan/HCTZ is a combination product of Valsartan and Hydrochlorothiazide, indicated for treating hypertension and congestive heart failure.
Unipharm’s generic Valsartan/HCTZ Tablets have been manufactured and marketed in Israel since 2011.
Strengths: 80/12.5, 160 /12.5 &160 /25 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect